Ticagrelor versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention

Dual antiplatelet therapy (DAPT) with ticagrelor or adjusted‐dose prasugrel has been used for acute coronary syndrome (ACS). However, few studies have directly compared these two drugs. In this study, we compared the real‐world applications and outcomes of these two drugs in patients with ACS who ha...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Clinical pharmacology and therapeutics Ročník 116; číslo 3; s. 747 - 756
Hlavní autori:	Tsai, Ming‐Lung, Lin, Yuan, Chen, Dong‐Yi, Lin, Ming‐Shyan, Wang, Chao‐Yung, Hsieh, I‐Chang, Yang, Ning‐I, Hung, Ming‐Jui, Chen, Tien‐Hsing
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.09.2024
Predmet:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - therapy Aged Female Hemorrhage - chemically induced Hemorrhage - epidemiology Humans Male Middle Aged Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride - administration & dosage Prasugrel Hydrochloride - adverse effects Prasugrel Hydrochloride - therapeutic use Retrospective Studies Ticagrelor - administration & dosage Ticagrelor - adverse effects Ticagrelor - therapeutic use Treatment Outcome
ISSN:	0009-9236, 1532-6535, 1532-6535
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!